Final Digital Program - Updated Post Meeting
Please note - Information listed in the Detailed Agenda is subject to changes and is continually updated to reflect the most up to date information.
9:00 a.m. – 12:00 p.m. |
|
||
8:30 a.m. – 6:00 p.m. |
Registration |
Centennial Foyer |
|
1:00 p.m. - 5:45 p.m. |
Mineral Hall D-G |
||
6:00 p.m. - 7:30 p.m. |
Mentor in a Cloud |
Mineral Hall A-C |
7:00 a.m. – 6:00 p.m. |
Registration |
Centennial Foyer |
|
8:30 a.m. - 12:00 p.m. |
VARIOUS ROOMS |
||
1:30 p.m. - 5:00 p.m. |
VARIOUS ROOMS |
||
12:00 p.m. - 1:00 p.m. |
Mid-Career Session |
Mineral Hall A-C |
|
Pathways to Senior Leadership: When You Get To The Top, How Do You Balance. |
|||
Panelist 1: |
Hugh Taylor, MD |
||
Panelist 2: |
Sarah Berga, MD |
||
Panelist 3: |
Richard E. Leach, MD |
||
Panelist 4: |
Amy Murtha, MD |
||
5:15 p.m. - 6:15 p.m. |
Early Career Forum |
Mineral Hall A - C |
|
How to Get Published: A Skills Workshop in Academic Publishing |
|||
Panelist 1: |
Irina Burd, MD, PhD |
||
Panelist 2: |
Erica Marsh, MD, MSCI, FACOG |
||
Panelist 3: |
Ayman Al-Hendy, MD, PhD |
||
Panelist 4: |
James Segars, MD |
||
6:30 p.m. - 7:30 p.m. |
Welcome Reception |
Centennial DE |
7:00 a.m. – 6:00 p.m. |
Registration |
Centennial Foyer |
|
8:30 a.m. - 8:40 a.m. |
President's Welcome |
Centennial DE |
|
8:40 a.m. - 9:30 a.m. |
President’s Distinguished Lecture I |
Centennial DE |
|
9:30 a.m. - 10:30 a.m. |
President’s New Investigator Plenary |
Centennial DE |
|
9:30 a.m. - 9:45 a.m. |
P-001: Dose-Response Profile and Minimal Duration of Administration of a Novel Anti-IL-1R Therapeutic, Rytvela, for Prevention of Preterm Birth and Neonatal Tissue Injury |
||
9:45 a.m. - 10:00 a.m. |
P-002: Continuous but Not Pulsed Steroid Exposures Extend the Durability of Antenatal Steroid Therapy in a Sheep Model of Pregnancy |
||
10:00 a.m. - 10:15 a.m. |
P-003: The Effect of COVID-19 mRNA Vaccine on Ovarian Reserve. |
||
10:15 a.m. - 10:30 a.m. |
P-004: Combination of Stem Cell Secreted and Platelet Enclosed Growth Factors Restores Ovarian Function in an Aging Mouse Model |
||
10:30 a.m. - 12:00 p.m. |
Poster Session I |
Centennial A-C |
|
12:00 p.m. - 1:30 p.m. |
Lunch and Learn Symposium I |
Centennial FG |
|
Race, Racism, and Reproductive Health - Rewriting the Narrative |
|
||
|
Implications for Race and Racism in Endometrial Cancer: A Case Study |
||
|
Addressing Disparate Maternal Outcomes: Creating the Research Agenda |
||
|
“Because Its Mine”: Uterine Fibroids, Health Disparities, and Unanswered Questions |
||
12:00 p.m. - 1:30 p.m. |
Lunch and Learn Symposium II |
Mineral Hall A-C |
|
How To Build a Successful Research Environment in Reproduction Part I: 12:00pm- 12:50pm Short Presentations |
|||
Panelists: |
|||
|
Genevieve Neal-Perry, MD, PhD |
||
|
Irene Cetin, MD |
||
|
Dineo Khabele, MD |
||
|
Stephen Matthews, PhD |
||
|
Yoel Sadovsky, MD |
||
12:00 p.m. - 1:30 p.m. |
Lunch & Learn III |
Mineral Hall D-G |
|
The Potential of the Oral GnRH Antagonist: a Personalized Approach for Women with Uterine Fibroids |
|||
|
Medical Treatment Options for Fibroids: Preserving uterine function for the future |
||
|
Providing Uterine-Preserving Treatment Options for Fibroids: Why & How |
||
|
The Psychosocial Impact and Racial Disparity of Uterine Fibroids |
||
1:45 p.m. - 3:45 p.m. |
Mini-Symposia I |
|
|
Current Concepts in Fertility Preservation Research |
Capitol 1-3 |
||
1:45 p.m. - 2:15 p.m. |
Chemotherapy-Induced Ovarian Toxicity and Preemption by Tissue Cryopreservation and Transplantation |
||
2:15 p.m. - 2:45 p.m. |
Scientific Progress in Pharmacologic Preservation of Fertility |
||
2:45 p.m. - 3:15 p.m. |
Fertility Preservation for Transgender Individuals |
||
3:15 p.m. - 3:45 p.m. |
In vitro maturation of primordial follicles and putative oogonial stem cells for fertility preservation |
||
Preeclampsia at High Altitude: Opportunities to Improve Our Understanding of this still Enigmatic Disease and Improve Treatments for Populations at Greatest Risk |
Capitol 4 |
||
1:45 p.m. - 2:15 p.m. |
Pre-eclampsia: a major killer of women and babies in Bolivia and paths toward reducing its impact |
||
2:15 p.m. - 2:45 p.m. |
Effects of pre-eclampsia at high altitude in utero and during infancy |
||
2:45 p.m. - 3:15 p.m. |
Placental mitochondria and metabolic adjustment to high-altitude hypoxia - physiological signals and clinical implications |
||
3:15 p.m. - 3:45 p.m. |
Gestation at high altitude and programming of maternal, fetal and newborn vascular function |
||
Adenomyosis: Navigating the Science and Clinical Paradigms |
Capitol 5-7 |
||
1:45 p.m. - 2:15 p.m. |
Update on Adenomyosis Pathogenesis and Pathophysiology |
||
2:15 p.m. - 2:45 p.m. |
Epidemiology of Adenomyosis- What We Know and Don't Know |
||
2:45 p.m. - 3:15 p.m. |
Multiple Ways to Diagnose and Classify Adenomyosis |
||
3:15 p.m. - 3:45 p.m. |
Current and Future Surgical, Medical and Interventional Approaches to Manage Adenomyosis |
||
Ovarian Steroids: The Path to Women’s Reproductive Health |
Mineral Hall A-C |
||
1:45 p.m. - 2:15 p.m. |
Endocrine Disruption and Ovotoxicity |
||
2:15 p.m. - 2:45 p.m. |
Androgen Actions and Women’s Health: The Goldilocks Principle |
||
2:45 p.m. - 3:15 p.m. |
Susceptibility of ovarian steroidogenic cells to environmental chemicals |
||
3:15 p.m. - 3:45 p.m. |
Restoration of ovarian steroidogenesis and function in premature ovarian insufficiency |
||
Maternal-Fetal Immunity: Gatekeepers or Peacekeepers? |
Mineral Hall D-G |
||
1:45 p.m. - 2:15 p.m. |
SARS-COV2 and the Trophoblast: Chewing the Fat and More |
||
2:15 p.m. - 2:45 p.m. |
Immune Cells at the Maternal Fetal Interface |
||
2:45 p.m. - 3:15 p.m. |
Innnate Immune Cells at the Maternal Fetal Interface |
||
3:15 p.m. - 3:45 p.m. |
Placental Regulation of Macrophage Function |
||
Women's Health Collaborative |
Centennial FG |
||
1:45 p.m. - 1:55 p.m. |
Introduction: Why patients, providers, and science need diversity |
||
1:55 p.m. - 2:20 p.m. |
Finding Your Voice: An International Perspective |
||
2:20 p.m. - 2:45 p.m. |
Women's Work and the Feminization of the OBGYN Workforce |
||
2:45 p.m. - 3:15 p.m. |
Building a career as a female physician-scientist in OBGYN |
||
3:15 p.m. - 3:45 p.m. |
More than grit: growing and sustaining physician-scientists in OBGYN |
||
3:45 p.m. - 4:00 p.m. |
Coffee Break |
Level 3 & |
|
4:00 p.m. - 6:00 p.m. |
Concurrent Oral Presentations I |
|
|
Clinical and Translational Perinatology I |
Capitol 1-3 |
||
4:00 p.m. - 4:15 p.m. |
O-009: Evidence of Increased Placental Capacity to Deliver Amino Acids and Fatty Acids in Obese Women with Gestational Diabetes |
||
4:15 p.m. - 4:30 p.m. |
O-010: Exposure of Gut Microbes to Maternal High Fat Diet Impacts Their Effect on Enteroids |
||
4:30 p.m. - 4:45 p.m. |
O-011: Maternal Age as a Risk Factor for Adverse Pregnancy Outcomes |
||
4:45 p.m. - 5:00 p.m. |
O-012: Association of Allostatic Load and Later Maternal Cardiovascular Outcomes |
||
5:00 p.m. - 5:15 p.m. |
O-013: Breastfeeding Promotes Predominant Bifidobacterium in Farm-Exposed Infants |
||
5:15 p.m. - 5:30 p.m. |
O-014: Adverse Obstetric Outcome in Dichorionic Diamniotic Twin Gestations Conceived with IVF vs Spontaneous Conception: A Multicenter Cohort Study |
||
5:30 p.m. - 5:45 p.m. |
O-015: Multiomics Modeling of Preterm Birth in Low- and Middle-Income Countries |
||
5:45 p.m. - 6:00 p.m. |
O-016: Assessment of Synthetic Erythrocyte Therapy for Extremely Preterm Ovine Fetuses Maintained on an Artificial Placenta Life-Support Platform |
||
Gynecology I |
Capitol 4 |
||
4:00 p.m. - 4:15 p.m. |
O-017: Estradiol Increases Antimicrobial Peptides to Prevent UTI Infections |
||
4:15 p.m. - 4:30 p.m. |
O-018: Racial Disparities in Surgical Management of Endometriosis: Pre-Surgical ED Visits, Pre-Operative Indications, and Fertility-Sparing Surgery |
||
4:30 p.m. - 4:45 p.m. |
O-019: Factors Associated with HPV Vaccination Among LatinX Females: Insights from the ELLAS Study |
||
4:45 p.m. - 5:00 p.m. |
O-020: Biomarkers of Immediate Postpartum Pelvic Floor Injury Correlate to Delivery Type |
||
5:00 p.m. - 5:15 p.m. |
O-021: Transcriptomic Profiling of Endometrium and Subcutaneous Adipose Tissues in Association with Endometriosis |
||
5:15 p.m. - 5:30 p.m. |
O-022: Deepening the Endometrial Preparation Through Systems Pharmacology Antonio Parraga-Leo, Patricia Sebastian-Leon, Almudena Devesa-Peiro, Jose Remohi, Antonio Pellicer, Patricia Diaz-Gimeno |
||
5:30 p.m. - 5:45 p.m. |
O-147: Longitudinal Assessment of Randomized, Placebo-Controlled Trial of Botulinum Toxin for Endometriosis-Associated Chronic Pelvic Pain |
||
5:45 p.m. - 6:00 p.m. |
O-148: Proteomic Discovery of Serum Biomarkers for Human Leiomyosarcoma |
||
Parturition I |
Capitol 5-7 |
||
4:00 p.m. - 4:15 p.m. |
O-023: Extracellular Vesicles from Gardnerella vaginalis and Mobiluncus mulieris Induce Host Immune Responses from the Cervicovaginal Epithelium |
||
4:15 p.m. - 4:30 p.m. |
O-024: Rapid Assessment of Vaginal Microbiota Host Interactions During Pregnancy and Preterm Birth by Direct On-Swab Desorption Electrospray Ionization Mass Spectrometry |
||
4:30 p.m. - 4:45 p.m. |
O-025: Novel Demonstration That the Interleukin (IL)-1 Receptor Antagonist, Rytvela, is Efficacious in Human Fetal Membrane (hFM) Explants and Peripheral Leukocytes |
||
4:45 p.m. - 5:00 p.m. |
O-026: N,N-Diethylacetamide Prevents Inflammation-Induced Preterm Birth in a Murine Model via the Nuclear Factor Kappa B Pathway |
||
5:00 p.m. - 5:15 p.m. |
O-027: Integrated Analysis Reveals Associations Between Cervical Neutrophil Gene Expression and Cervicovaginal Microbiota in Women at High Risk of Preterm Birth |
||
5:15 p.m. - 5:30 p.m. |
O-028: MCJ/DNAJC15 Deficiency Protects Against LPS Induced Preterm Birth in Mice |
||
5:30 p.m. - 5:45 p.m. |
O-029: Membrane and Fetal Brain Inflammatory Gene Expression in a Non-Human Primate Model of Choriodecidual Ureaplasma Infection |
||
5:45 p.m. - 6:00 p.m. |
O-030: Exosomes from Ureaplasma Parvum-Infected Ectocervical Epithelial Cells Promote Cervical and Decidual Inflammation but Not Sufficient to Cause Preterm Delivery |
||
Placenta I |
Mineral Hall A-C |
||
4:00 p.m. - 4:15 p.m. |
O-031: Spatial and Temporal Dynamics of Decidual Maternal and Fetal Cell Populations by Multiplexed Ion Beam Imaging (MIBI-TOF) |
||
4:15 p.m. - 4:30 p.m. |
O-032: Epigenetic Regulation by DNA N(6)-Methyladenine in Placental Tissue is Necessary for Embryonic Development |
||
4:30 p.m. - 4:45 p.m. |
O-033: The Utero-Placental Vascular Skeleton and the Association with First-Trimester Embryo Development: The Rotterdam Periconception Cohort |
||
4:45 p.m. - 5:00 p.m. |
O-034: Involvement of EPAS1/HIF2A in Trophoblast Lineage and Placental Development |
||
5:00 p.m. - 5:15 p.m. |
O-035: 2-Methoxyestradiol Levels Are Altered by Cycle Type in ART and May Play a Role in Abnormal Placentation |
||
5:15 p.m. - 5:30 p.m. |
O-036: Discovery and Validation of Molecular Signatures of Arterial-Venous Endothelial Heterogeneity in Large and Small Umbilical-Placental Vessels |
||
5:30 p.m. - 5:45 p.m. |
O-037: Photo-Responsive Nanoparticles for Diagnostic Imaging and Treatment of Ectopic Pregnancy |
||
5:45 p.m. - 6:00 p.m. |
O-038: Chronic Prenatal Marijuana Exposure Alters Placental Gene Expression in a Non-Human Primate Model |
||
Maternal Biology and Health |
Mineral Hall D-G |
||
4:00 p.m. - 4:15 p.m. |
O-001: Perfluorooctane Sulfonic Acid (PFOS) Increases Mean Arterial Pressure by Impairing Endothelial Nitric Oxide-Mediated Vasodilation and Enhancing Angiotensin II-Mediated Vascular Contraction in Pregnant Rats |
||
4:15 p.m. - 4:30 p.m. |
O-002: Piezo1 in the Endothelial Cells Modulates Collagen Organization and is Involved in Uterine Arterial Remodeling |
||
4:30 p.m. - 4:45 p.m. |
O-003: Global Ablation of Adrenomedullin2 Results in Abnormal Glucose Metabolism in Mice Pregnancy |
||
4:45 p.m. - 5:00 p.m. |
O-004: New Chronic Hypertension 6-12 Months Following a Pregnancy Complicated by a Hypertensive Disorder of Pregnancy |
||
5:00 p.m. - 5:15 p.m. |
O-005: Stronger Blood-Brain Barrier Leakage Years After Preeclampsia: A Dynamic Contrast-Enhanced MRI Study at 7 Tesla |
||
5:15 p.m. - 5:30 p.m. |
O-006: Sulfhydration of β1 Subunit Mediates H2S-Stimulated Activation of Human Uterine Artery Smooth Muscle BKCa Channels |
||
5:30 p.m. - 5:45 p.m. |
O-007: Commensal F. nucleatum Bacterium Regulates the Expression of Pro-Angiogenic Factors In Vitro via PAR-1 Pathway |
||
5:45 p.m. - 6:00 p.m. |
O-008: Pregnancy-Specific Paracrine Factors Change Uterine Vascular Reactivity to Allow Increasing Blood Flow to the Placenta |
||
Reproductive Biology I |
Centennial FG |
||
4:00 p.m. - 4:15 p.m. |
O-039: Single Cell Transcriptome Description of Early Development Haploid Androgenotes and Parthenotes |
||
4:15 p.m. - 4:30 p.m. |
O-040: Bisphenol-AF Increases the Cell Number and Modulates Estrogen and Progesterone Receptor Expression in Mouse Blastocyst |
||
4:30 p.m. - 4:45 p.m. |
O-041:ERβ Regulated Indian Hedgehog Signaling in the First Wave of Ovarian Follicles |
||
4:45 p.m. - 5:00 p.m. |
O-042: Exposure to Synthetic Glucocorticoids Modifies the microRNA Cargo of Epididymal Extracellular Vesicles: Implications for Intergenerational Transmission |
||
5:00 p.m. - 5:15 p.m. |
O-043: Cross-Species Analysis of Wnt Pathway Involvement During Preimplantation Development and Lineage Specification In the Human and the Mouse |
||
5:15 p.m. - 5:30 p.m. |
O-044: Mechanistic Opposition of TNFα and AMH upon Integrated Stress Response Activity in Granulosa Cells |
||
5:30 p.m. - 5:45 p.m. |
O-045: Novel Anti-Mullerian Hormone Receptor 2 Binding Peptide (AMHR2BP) Modulates Preantral Follicle Development In Vitro |
||
5:45 p.m. - 6:00 p.m. |
O-046: Murine Oocyte Maturation and Developmental Competence Using Biocompatible Hydrogel Based on Decellularized Bovine Ovarian Cortex |
||
6:00 p.m. - 7:30 p.m. |
Connection Corners |
Centennial Foyer |
7:00 a.m. – 6:00 p.m. |
Registration |
Centennial Foyer |
|
8:00 a.m. - 9:00 a.m. |
President’s Distinguished Lecture II |
Centennial DE -Level 3- |
|
9:00 a.m. - 10:30 a.m. |
Poster Session II |
Centennial A-C -Level 3- |
|
10:30 a.m. - 12:00 p.m. |
Concurrent Oral Presentations II |
|
|
Developmental Programming I |
Capitol 1-3 |
||
10:30 a.m. - 10:45 a.m. |
O-047: Maternal Melatonin < Effective Intervention Against Programmed Heart Disease Male and Female Adult Offspring of Hypoxic Pregnancy |
||
10:45 a.m. - 11:00 a.m. |
O-048: Loss of Liver Expressed Circadian Gene Npas2 Alters the Murine Functional Gut Microbiome at Light/Dark Timepoints |
||
11:00 a.m. - 11:15 a.m. |
O-049: Maternal Glucagon-Like Peptide-1 is Positively Associated with Fetal Growth in Pregnancies Complicated with Obesity |
||
11:15 a.m. - 11:30 a.m. |
O-050: Maternal Omega-3 Fatty Acid-Enriched Diet Rescues Impaired Cardiac Function in Rat Offspring Exposed to Δ9-tetrahydrocannabinol In Utero |
||
11:30 a.m. - 11:45 a.m. |
O-149: Fetal Maternal Origin (FeMO) of Cells in Placental Tissue Using Single Cell RNA-Seq Data |
||
11:45 a.m. - 12:00 p.m. |
O-150: Regulation of Embryonic Lineage in the Mammalian Preimplantation Embryo by miRNAs |
||
Fetus I |
Capitol 4 |
||
10:30 a.m. - 10:45 a.m. |
O-051: Sex-Specific Differences in the Placental UPR Pathways in a Rat Model of Fetal Hypoxia |
||
10:45 a.m. - 11:00 a.m. |
O-052: Gestational Hypoxia Alters Fetal Cardiac Mitochondrial Function and Reactive Oxygen Species Production in a Sex-Dependent Manner |
||
11:00 a.m. - 11:15 a.m. |
O-053: Fetal and Placental Endothelial Mechanosensor Downregulation in Human Pregnancy Complicated by Fetal Growth Restriction and Hypoxia |
||
11:15 a.m. - 11:30 a.m. |
O-054: Chronic Prenatal Marijuana Use Results in Ischemic Fetal Brain Injury in a Rhesus Macaque Model |
||
11:30 a.m. - 11:45 a.m. |
O-055: Tissue Specific Responses That Constrain Glucose Oxidation and Increase Lactate Production in Association with the Severity of Hypoxemia in Late Gestation Fetal Sheep |
||
11:45 a.m. - 12:00 p.m. |
O-056: Evaluation of Umbilical Vein Blood Flow, Fetal Oxygen and Glucose Uptake in Uncomplicated Monochorionic Twins |
||
Preeclampsia I |
Capitol 5-7 |
||
10:30 a.m. - 10:45 a.m. |
O-069: Preeclampsia Differentially Dysregulates Female and Male Fetal Endothelial Cells Function and Transcriptomic Profiles in Lean and Obese Pregnancies. |
||
10:45 a.m. - 11:00 a.m. |
O-070: Genome-Wide Association Study Reveals Genetic Variants Associated with Hypertensive Pregnancy Disorders. |
||
11:00 a.m. - 11:15 a.m. |
O-071: Syncytiotrophoblast-Derived Extracellular Vesicles from Normal and Preeclamptic Pregnancies Impair Endothelial Function via Reduced Nitric Oxide Availability |
||
11:15 a.m. - 11:30 a.m. |
O-072: Bisoprolol Alters Chorionic Plate Artery Reactivity |
||
11:30 a.m. - 11:45 a.m. |
O-073: Preeclampsia Increases Risk of Maternal Pulmonary Hypertension at High Altitude in Bolivia |
||
11:45 a.m. - 12:00 p.m. |
O-074: Single-Cell Atlas of Defective Decidualization in Preeclampsia Reveals Different Endometrial Cell Composition. |
||
Gynecology II |
Mineral Hall A-C |
||
10:30 a.m. - 10:45 a.m. |
O-057: NOTCH1 Promotes Epithelial-Mesenchymal Transition During Endometriotic Lesion Development |
||
10:45 a.m. - 11:00 a.m. |
O-058: Endometrial Stromal Cells from Endometriosis Subjects Exhibit Reduced Progesterone Sensitivity Compared to Control Cells |
||
11:00 a.m. - 11:15 a.m. |
O-059: Safety and Efficacy Analysis of Endometriosis Drugs Towards Precision Medicine |
||
11:15 a.m. - 11:30 a.m. |
O-060: The Role of IL-23 and the IL-23/TH17 Axis in Endometriosis Pathophysiology |
||
11:30 a.m. - 11:45 a.m. |
O-061: Characterisation of Novel In Vitro 3D Cell Culture Model of Adenomyosis Alison Maclean, Christopher J Hill, Dharani K Hapangama |
||
11:45 a.m. - 12:00 p.m. |
O-062: Hypoxia Induces Proliferation via NOX4-Mediated ROS Generation and TGF-β3 Pathway in Uterine Leiomyoma Cells |
||
Parturition II |
Mineral Hall D-G |
||
10:30 a.m. - 10:45 a.m. |
Withdrew - |
||
10:45 a.m. - 11:00 a.m. |
O-064: Mapping the Mechanical Properties of Nonhuman Primate Cervix to Inform Quantitative Ultrasound Measurements |
||
11:00 a.m. - 11:15 a.m. |
O-065: Shift in Specific Epithelial Subtypes Ensures Cervical Immunoprotection in Pregnancy |
||
11:15 a.m. - 11:30 a.m. |
O-066: Promegestone Regulates Local Metabolism of Progesterone, Cervical Remodelling and Timing of Labour Onset in Mice |
||
11:30 a.m. - 11:45 a.m. |
O-067: Distinct Transcription Factors Drive Changes in Chromatin Accessibility in the Pregnant and Labouring Myometrium. |
||
11:45 a.m. - 12:00 p.m. |
O-068: Repurposing FDA-Approved Drugs for Novel Tocolytic Use in Mono and Combination Therapy to Mitigate Preterm Labor |
||
Reproductive Endocrinology and Infertility I |
Centennial FG |
||
10:30 a.m. - 10:45 a.m. |
O-075: Deciphering the Role of PGRMC2 in Decidualization and Trophoblast Invasion Using Primary In Vitro Models |
||
10:45 a.m. - 11:00 a.m. |
O-076: Endometrial Adhesion G Protein-Coupled Receptor (ADGR) Gene Expression is Altered with Ovarian Stimulation |
||
11:00 a.m. - 11:15 a.m. |
O-077: Eucaloric High Fat Diet Induction of Reprometabolic Syndrome in Normal Weight Women. |
||
11:15 a.m. - 11:30 a.m. |
O-078; Comparison Study of Therapeutic Effect Between Stem Cell vs. Exosome in Primary Ovarian Insufficiency |
||
11:30 a.m. - 11:45 a.m. |
O-079: Enhancing Development of Murine Follicles In Vitro Using Extracellular Matrix from Decellularized Bovine Ovarian Cortex. |
||
11:45 a.m. - 12:00 p.m. |
O-080: Preconceptional Maternal Prorenin and the Impact on Oocyte Morphology and Preimplantation Embryo Quality as Assessed by Morphokinetics: The Rotterdam |
||
12:00 p.m. - 1:30 p.m. |
Editor Roundtable |
Mineral Hall D-G |
|
Panelist 1: |
Salvatore Fabbiano |
||
Panelist 2: |
Ayman Al-Hendy. MD, PhD |
||
Panelist 3: |
William H. Catherino, MD, PhD |
||
Panelist 4: |
Marianna Alperin, MD, MS |
||
12:00 p.m. - 1:30 p.m. |
Diversity, Equity and Inclusion Forum |
Centennial Ballroom FG |
|
Celebrating Women in Science and Leadership |
|||
Panelist 1:
|
Amy Murtha, MD |
||
Panelist 2:
|
Dineo Khabele, MD |
||
Panelist 3:
|
Cynthia Gyamfi-Bannerman, MD |
||
Panelist 4:
|
Sarah Berga, MD |
||
Panelist 5:
|
Elizabeth Garner, MD, MPH |
||
12:00 p.m. - 1:00 p.m. |
Past President's Lunch |
|
|
1:45 p.m. - 3:45 p.m. |
Mini-Symposia II |
|
|
SSR/SRI Joint Session: Biologic Activity of Age-related FSH Glycoforms |
Capitol Ballroom 1-3 |
||
1:45 p.m. - 2:15 p.m. |
Changing Patterns of FSH Glycosylation Across the Reproductive Lifespan |
||
2:15 p.m. - 2:45 p.m. |
Differential Actions of FSH glycoforms in Traditional and Nontraditional FSH targets |
||
2:45 p.m. - 3:15 p.m. |
Functional Analysis of Age-specific FSH Glycoforms Using Genetically Altered Mice |
||
3:15 p.m. - 3:45 p.m. |
Decoding the Effect of FSH Glycosylation on FSHR Oligomerization |
||
Bioengineering in Pelvic Floor Disorders |
Capitol Ballroom 4 |
||
1:45 p.m. - 2:15 p.m. |
Strategies to prevent pelvic floor muscle damage postpartum |
||
2:15 p.m. - 2:45 p.m. |
Smooth muscle regional contribution to vaginal wall function |
||
2:45 p.m. - 3:15 p.m. |
Addressing the mechanisms mediating the adverse effects of transvaginal mesh by using new biomaterials |
||
3:15 p.m. - 3:45 p.m. |
Nanobiomaterials and endometrial Mesenchymal Stem Cells for treating and preventing Pelvic Organ Prolapse |
||
New Insights into PCOS |
Capitol Ballroom 5-7 |
||
1:45 p.m. - 2:15 p.m. |
New insights into the long term health issues in PCOS |
||
2:15 p.m. - 2:45 p.m. |
AMH and its role in the Pathophysiology of PCOS |
||
2:45 p.m. - 3:15 p.m. |
New insights into the health of the offspring of mothers with PCOS |
||
3:15 p.m. - 3:45 p.m. |
PCOS Diagnostic criteria: A critical reappraissal |
||
Placental Lipids: The Plot Thickens |
Mineral Hall A-C |
||
1:45 p.m. - 2:15 p.m. |
Novel role for phospholipids in human placenta |
||
2:15 p.m. - 2:45 p.m. |
The role of bioactive lipids on the preeclamptic placenta : Endocannabinoids as new target? |
||
2:45 p.m. - 3:15 p.m. |
Lipid metabolism by trophoblast |
||
3:15 p.m. - 3:45 p.m. |
Impact of placental lipid metabolism on delivery to the fetus |
||
Extracellular Vesicles in Development and Disease |
Mineral Hall D-G |
||
1:45 p.m. - 2:15 p.m. |
Placental EVs Associated with Pregnancy Outcomes |
||
2:15 p.m. - 2:45 p.m. |
Nanoscale Flow Cytometry to Image, Count, and Isolate EVs |
||
2:45 p.m. - 3:15 p.m. |
Translational Potential of CNS Derived Extracellular Vesicles |
||
3:15 p.m. - 3:45 p.m. |
Role of Extracellular Vesicles in Endometriosis Pathophysiology |
||
Fetal Sex and the Impact on Placental Biology and Neonatal Outcome |
Centennial Ballroom FG |
||
1:45 p.m. - 2:15 p.m. |
Functional consequences of X chromosome inactivation escape in the placenta |
||
2:15 p.m. - 2:45 p.m. |
Sex differences in DNA methylation in the placenta |
||
2:45 p.m. - 3:15 p.m. |
Sex-dependent fetoplacental adaptations to early environments – contributors to lifecycle health trajectories? |
||
3:15 p.m. - 3:45 p.m. |
Sexual dimorphism in placental metabolism - consequences for fetal growth and outcomes in adverse conditions |
||
3:45 p.m. - 4:00 p.m. |
Coffee Break |
Level 3 & Level 4 Foyers |
|
4:00 p.m. - 5:30 p.m. |
Concurrent Oral Presentations III |
|
|
Epidemiology and Global Health |
Capitol 1-3 |
||
4:00 p.m. - 4:15 p.m. |
O-093: Heterogeneity in the Genetic Basis of Preterm Delivery and Gestational Duration and their Links with Other Pregnancy and Reproductive Traits |
||
4:15 p.m. - 4:30 p.m. |
O-094: Vaginal Detection of Interferon Epsilon is Associated with Preterm Preeclampsia |
||
4:30 p.m. - 4:45 p.m. |
O-095: Maternal Diet Quality is Associated with Placental Proteins in the Placental Insulin/Growth Factor, Environmental Stress, Inflammation, and mTOR Signaling Pathways: The Healthy Start ECHO Cohort |
||
4:45 p.m. - 5:00 p.m. |
O-096: Association of Risk of Small for Gestational Age with Selective Serotonin Reuptake Inhibitor Use |
||
5:00 p.m. - 5:15 p.m. |
O-097: Associations Between Hypertensive Disorders of Pregnancy and Change in Cognitive Function, The Hispanic Community Health Study/Study of Latinos, 2008-2018 |
||
5:15 p.m. - 5:30 p.m. |
O-098: Effectiveness of EHealth Coaching Using Smarter Pregnancy on Improving Dietary and Other Lifestyle-Related Behaviours: Can Attitudes Predict Practices? |
||
Developmental Programming II |
Capitol 4 |
||
4:00 p.m. - 4:15 p.m. |
O-087: Susceptibility to Arrhythmia in Offspring of Hypoxic Pregnancy: Spontaneous Calcium Release in Isolated Cardiomyocytes |
||
4:15 p.m. - 4:30 p.m. |
O-088: Offspring of Obese Mice Have Islet Beta-Cell Dysfunction Which is Prevented by Normalization of Maternal Adiponectin Levels in Late Pregnancy |
||
4:30 p.m. - 4:45 p.m. |
O-089: Pregnancy Following Resolved Acute Kidney Injury Results in Growth-Restricted Offspring in Mice |
||
4:45 p.m. - 5:00 p.m. |
O-090: Cord Blood Metabolomics and Autism Spectrum Disorder |
||
5:00 p.m. - 5:15 p.m. |
O-091: Prenatal Low Protein Diet Affects Mitochondrial Structure and Function in the Skeletal Muscle of Adult Female Offspring |
||
5:15 p.m. - 5:30 p.m. |
O-092: Maternal Western Diet Exposure Decreases Fetal Amino Acid Uptake and Hepatic Antioxidant Production Yet Primes Hepatocyte Gluconeogenic Response in Non-Human Primates |
||
Placenta II |
Mineral Hall A-C |
||
4:00 p.m. - 4:15 p.m. |
O-099: CDKN1C is a Regulator of the Extravillous Trophoblast Cell Lineage |
||
4:15 p.m. - 4:30 p.m. |
O-100: Hypoxic Pregnancy in Sheep Alters Placental Mitochondrial Function, Structure and Energy Metabolism |
||
4:30 p.m. - 4:45 p.m. |
O-101: Placental Endothelial Cells in Severe Fetal Growth Restriction Exhibit Aberrant Adhesion to Collagen IV |
||
4:45 p.m. - 5:00 p.m. |
O-102: Circadian Rhythms in the Fetus and the Placenta Develop and Change During Gestation |
||
5:00 p.m. - 5:15 p.m. |
O-103: Placenta Specific Knockdown of MFSD2a, a Lysophosphatidylcholine Transporter, Results in DHA Deficiency in the Fetal Brain |
||
5:15 p.m. - 5:30 p.m. |
O-104: Varying Degrees of Fetal Growth Restriction in Chorionic Somatomammotropin RNA Interference Pregnancies |
||
Reproductive Biology II |
Capitol 5-7 |
||
4:00 p.m. - 4:15 p.m. |
O-105: The Guinea Pig Embryo: A Potential New Model for Human Development |
||
4:15 p.m. - 4:30 p.m. |
O-106: Untargeted Metabolomic Identification of Diagnostic Biomarkers in Ectopic Pregnancy |
||
4:30 p.m. - 4:45 p.m. |
O-107: Glucocorticoid Signaling Critically Mediates Human Endometrial Stromal Cell Decidualization |
||
4:45 p.m. - 5:00 p.m. |
O-108: Exposure to Bone Marrow-Derived Mesenchymal Stem Cell Secretome Alters Gene Expression in Human Endometrial Stromal Cells |
||
5:00 p.m. - 5:15 p.m. |
O-109: Entosis Act Through the Rho-ROCK Signalling Pathway During Human Embryo Implantation |
||
5:15 p.m. - 5:30 p.m. |
O-151: Tyro3 as a Novel Molecular Insight to Endometriosis |
||
Reproductive Endocrinology and Infertility II |
Mineral Hall D-G |
||
4:00 p.m. - 4:15 p.m. |
O-110: Ibuprofen Reduces Testosterone Level in Women with Polycystic Ovary Syndrome |
||
4:15 p.m. - 4:30 p.m. |
O-111: Choline Synthesis and Cognition in Postmenopausal Women |
||
4:30 p.m. - 4:45 p.m. |
O-112: Novel Actions of Chemotherapy on Extracellular Vesicle Release and Their Impact in the Prepubertal Testis |
||
4:45 p.m. - 5:00 p.m. |
O-113: Perfluoroalkyl and Polyfluoroalkyl Substances and AMH Concentrations in Two Preconception Cohort Studies. |
||
5:00 p.m. - 5:15 p.m. |
O-152: Polycystic Ovarian Syndrome in Vitro on a Novel Multi-Organ Microfluidic Platform |
||
5:15 p.m. - 5:30 p.m. |
O-153: Differences in Circulating miRNA Signatures in Women with Extreme PCOS Phenotypes |
||
Clinical and Translational Perinatology II |
Centennial FG |
||
4:00 p.m. - 4:15 p.m. |
O-082: Detection of miR-150-5p Directly from Plasma on a Lateral Flow Assay Identifies Women at Risk of Preterm Birth |
||
4:15 p.m. - 4:30 p.m. |
O-083: Integrated View of the Maternal and Placental Contribution to Preterm Birth Syndrome |
||
4:30 p.m. - 4:45 p.m. |
O-084:Single Second Trimester Cervical Length is Predictive of Preterm Delivery Among Patients with History-Indicated Cerclage |
||
4:45 p.m. - 5:00 p.m. |
O-085: Endogenous Fatty Acid Derivatives Prevent Maternal Stress Induced Preterm Birth in Mice |
||
5:00 p.m. - 5:15 p.m. |
O-157: A Model of Long-Term Group B Streptococcus Vaginal Colonization and Subsequent Pregnancy |
||
5:15 p.m. - 5:30 p.m. |
O-158:A Placental Atlas of Parturition: Transcriptomic Signatures of Spontaneous Preterm Birth and Labor and Delivery Status in Two Birth Cohorts |
||
5:45 p.m. - 7:00 p.m. |
Presidential Address and Awards Ceremony |
Centennial DE |
|
|
|||
8:30 p.m. - 11:00 p.m. |
The Featles Mountain Tour |
Centennial DE |
7:00 a.m. – 1:00 p.m. |
Registration |
Centennial Foyer |
||
8:30 a.m. - 9:30 a.m. |
SRI Business Meeting |
Centennial DE |
||
9:30 a.m. - 11:00 a.m. |
Concurrent Oral Presentations IV |
|
||
Fetus II |
Capitol 1-3 |
|||
9:30 a.m. - 9:45 a.m. |
O-120: Preliminary Steps Toward Fetal Gene Therapy: Disruption of Bcl11a Erythroid-Specific Enhancer Region with CRISPR/Cas9 |
|||
9:45 a.m. - 10:00 a.m. |
O-121: P2X7 Receptor Blockade Prevents Perinatal Brain Injury in a Mouse Model of Congenital Cytomegalovirus (cCMV) Infection |
|||
10:00 a.m. - 10:15 a.m. |
O-122: Marijuana Use Alters Fetal Cerebral Spinal Fluid Extracellular Vesicles in a Rhesus Macaque Model |
|||
10:15 a.m. - 10:30 a.m. |
O-123: Effects of Maternal Beetroot Juice Supplementation on Feto-Placental Outcomes in a Mouse Model of Maternal Obesity |
|||
10:30 a.m. - 10:45 a.m. |
O-124: Protective Effects of Hydrogen Sulfide on Cardiac Function in the Hypoxic Chicken Embryo |
|||
10:45 a.m. - 11:00 a.m. |
O-125: Sex-Dependent Changes to TGF-β Signaling in Growth Restricted Fetal Guinea Pig Brains, with and without Placenta Nanoparticle Treatment |
|||
Health Disparities and COVID |
Capitol 4 |
|||
9:30 a.m. - 9:45 a.m. |
O-114: Impact of an Early Postpartum Access to Care Program on Maternal Morbidity and Mortality |
|||
9:45 a.m. - 10:00 a.m. |
O-115: Dispelling Damaging Myths: BNT162b2 COVID-19 Vaccine Does Not Affect Fertility and Pregnancy Rate in Women Undergoing IVF Treatment |
|||
10:00 a.m. - 10:15 a.m. |
O-159: Blunted Cortisol Awakening Response May Be Linked to Racial Discrimination During Pregnancy |
|||
10:15 a.m. - 10:30 a.m. |
O-117: Immunohistochemical Evidence of SARS-CoV-2 in the Placenta After Infection During Pregnancy: A Prospective Case-Control Study |
|||
10:30 a.m. - 10:45 a.m. |
O-118: Evaluating the Risk of Maternal SARS-CoV-2 Infection on Birth Outcomes in the Time of Delta and Vaccines |
|||
10:45 a.m. - 11:00 a.m. |
O-119: Placental Immune Responses to SARS-CoV-2: A Codex for Preventing Vertical Transmission? |
|||
Placenta III |
Capitol 5-7 |
|||
9:30 a.m. - 9:45 a.m. |
O-131: Atypical Protein Kinase-c Isoforms Regulate the Structure of the Syncytiotrophoblast Apical Surface |
|||
9:45 a.m. - 10:00 a.m. |
O-132: Associations Between Inflammatory Biomarkers During Pregnancy and Placental Pathology |
|||
10:00 a.m. - 10:15 a.m. |
O-133: Establishment of Human Trophoblast Organoids Derived from On-Going Pregnancies with Different Genetic Conditions |
|||
10:15 a.m. - 10:30 a.m. |
O-134: Viral dsDNA Suppresses Dexamethasone-Induced CD163 in Placental Hofbauer Cells: Implications for Viral Effects on HBC Function |
|||
10:30 a.m. - 10:45 a.m. |
O-155: Genetic P2X7 Receptor Blockade Diminishes Placental Trophoblast and Endothelial Injury and Infectious Viral Titer in a Mouse Model of Congenital Cytomegalovirus |
|||
10:45 a.m. - 11:00 a.m. |
O-156: Mistaken Identity as Placental Microbiome? Amplification of Microbial DNA from Outer Membrane Vesicles of Bacteria from Human Placenta. |
|||
Reproductive Biology III |
Mineral Hall A-C |
|||
9:30 a.m. - 9:45 a.m. |
O-141: Decidualization Dampens Endometrial Stromal Cell Inflammatory Responses to Infectious Triggers by Upregulating the NFkB Negative Regulator, IkB. |
|||
9:45 a.m. - 10:00 a.m. |
O-142: Women with Reproductive Failures Have Dysregulated Th1/Th2, Th17/Treg, and NK Cell Immunity. |
|||
10:00 a.m. - 10:15 a.m. |
O-160: Granulosa Cell Epigenetic Age Acceleration is Associated with Ovarian Reserve. |
|||
10:15 a.m. - 10:30 a.m. |
O-144: Human Bone Marrow Mesenchymal Stem Cell Derived Exosomes Protect OGCs from Cyclophosphamide Induced Cytotoxicity Augment Cell Proliferation and Inhibit Apoptosis |
|||
10:30 a.m. - 10:45 a.m. |
O-145: Murine Fetal Lung-Derived Amniotic Fluid Macrophages Are Polarized to a TAM-like State Prior to Labor at Term |
|||
10:45 a.m. - 11:00 a.m. |
O-146: Identification of Key Transcription Factors Regulating Extravillous Trophoblasts Specification |
|||
Preeclampsia II |
Mineral Hall D-G |
|||
9:30 a.m. - 9:45 a.m. |
O-135: A Novel NF-κB Variant Associated with Preeclampsia and Reduced Birth Weight in High-Altitude Andeans |
|||
9:45 a.m. - 10:00 a.m. |
O-136: Hofbauer Cells (HBCs) Effectively Combat Inflammatory Burden in Preeclampsia (PE) |
|||
10:00 a.m. - 10:15 a.m. |
O-137: CD4+T Cells Cause Increased Glucose, Hypertension, and Mitochondrial Dysfunction in a Novel Rodent Model of Gestational Diabetes Mellitus |
|||
10:15 a.m. - 10:30 a.m. |
O-138: Toll-Like Receptor 9 Stimulation During Pregnancy Induces Maternal Tachycardia and Disrupts Circadian Rhythm of Blood Pressure |
|||
10:30 a.m. - 10:45 a.m. |
O-139: Comprehensive Metabolic Profiling of Healthy Pregnancies versus Pregnancies Complicated by Preeclampsia: A Longitudinal Study |
|||
10:45 a.m. - 11:00 a.m. |
O-140: Preeclampsia Prediction from ECG Data. |
|||
Gynecology Oncology |
|
|||
9:30 a.m. - 9:45 a.m. |
O-126: Homologous Recombination Deficiency (HRD) Signature-3 in Ovarian and Uterine Carcinosarcomas Correlates with Preclinical Sensitivity to Olaparib, a Poly |
|||
9:45 a.m. - 10:00 a.m. |
O-127: Epigenetic Therapy Resensitizes Ovarian Cancer to PARPi Treatment and Reactivates Transposable Elements |
|||
10:00 a.m. - 10:15 a.m. |
O-128: PAX8-Directed Nanotherapeutics for High-Grade Serous |
|||
10:15 a.m. - 10:30 a.m. |
O-129: The Inhibitory Effect of Statins on Distant Metastasis of Endometrial Cancer |
|||
10:30 a.m. - 10:45 a.m. |
O-130: Tumor and Stromal AXL Expression Regulate Ovarian Cancer Metastasis |
|||
10:45 a.m. - 11:00 a.m. |
O-154: Patient-Derived Ovarian Organoid Living Tissue Bank |
|||
11:00 a.m. - 12:15 p.m. |
Hot Topics & Awards Ceremony |
Centennial DE |
||
11:00 a.m. - 11:15 a.m. |
O-161: Pleiotrophin and Fatty-acid Amide Hydrolase 2: Placenta-derived Biomarkers of Preeclampsia? |
|||
11:15 a.m. - 11:30 a.m. |
O-162: Maternal Immune Response and Placental Antibody Transfer After COVID-19 Vaccination Across Trimester and Platforms |
|||
11:30 p.m. - 12:15 p.m. |
Awards Ceremony
|